Penserra Capital Management’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-7,570
Closed -$390K – 1301
2023
Q1
$390K Buy
7,570
+1,392
+23% +$75.9K 0.01% 556
2022
Q4
$322K Buy
6,178
+614
+11% +$33.7K 0.01% 578
2022
Q3
$314K Buy
5,564
+540
+11% +$34K 0.01% 510
2022
Q2
$304K Sell
5,024
-269
-5% -$15.3K 0.01% 564
2022
Q1
$312K Buy
5,293
+1,188
+29% +$67.6K 0.01% 617
2021
Q4
$235K Buy
4,105
+2,695
+191% +$149K 0.01% 641
2021
Q3
$75K Buy
+1,410
New +$88.1K ﹤0.01% 919
2017
Q4
– Sell
-540
Closed -$41K – 507
2017
Q3
$41K Buy
+540
New +$42.2K 0.01% 324
2017
Q1
– Sell
-418
Closed -$31K – 752
2016
Q4
$31K Buy
418
+54
+15% +$3.96K ﹤0.01% 438
2016
Q3
$28K Buy
364
+136
+60% +$10.7K ﹤0.01% 436
2016
Q2
$17K Hold
228
– – ﹤0.01% 490
2016
Q1
$15K Buy
228
+46
+25% +$2.84K ﹤0.01% 478
2015
Q4
$11K Buy
+182
New +$10.9K ﹤0.01% 506

Other funds holding NHI

Penserra Capital Management's NHI Position: Q2 2023 in Review

Penserra Capital Management sold out of National Health Investors (NHI) in Q2 2023, closing a stake of 7,570 shares — an estimated $390K sold.

Penserra Capital Management first reported a position in NHI in Q4 2015 and held it in 13 quarters. The position peaked at $390K in Q1 2023. 211 funds tracked by Wall St. Rank hold NHI as of Q2 2023.

  • Penserra Capital Management reported no remaining National Health Investors position as of Q2 2023 after selling out during the quarter.
  • Penserra Capital Management sold 7,570 National Health Investors shares in Q2 2023, an estimated $390K.
  • Penserra Capital Management first reported a position in National Health Investors in Q4 2015 and held it in 13 quarters.
  • Penserra Capital Management's National Health Investors position peaked at $390K in Q1 2023.
  • 211 funds tracked by Wall St. Rank held National Health Investors as of Q2 2023.

Based on Penserra Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.